MESO |
Mesothelioma |
0.001 |
0.929 |
<0.001 |
LAML |
Acute Myeloid Leukemia |
0.002 |
0.553 |
<0.001 |
LUAD |
Lung adenocarcinoma |
0.003 |
0.881 |
<0.001 |
UCEC |
Uterine Corpus Endometrial Carcinoma |
0.025 |
0.746 |
<0.001 |
THCA |
Thyroid carcinoma |
0.031 |
0.938 |
<0.001 |
ESCA |
Esophageal carcinoma |
0.039 |
0.936 |
<0.001 |
PCPG |
Pheochromocytoma and Paraganglioma |
0.058 |
0.136 |
0.066 |
STAD |
Stomach adenocarcinoma |
0.067 |
0.690 |
<0.001 |
SKCM |
Skin Cutaneous Melanoma |
0.069 |
0.321 |
<0.001 |
LUSC |
Lung squamous cell carcinoma |
0.084 |
0.891 |
<0.001 |
CHOL |
Cholangiocarcinoma |
0.114 |
0.669 |
<0.001 |
CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
0.132 |
0.913 |
<0.001 |
PRAD |
Prostate adenocarcinoma |
0.134 |
0.651 |
<0.001 |
GBM |
Glioblastoma multiforme |
0.139 |
0.147 |
0.057 |
SARC |
Sarcoma |
0.169 |
0.533 |
<0.001 |
THYM |
Thymoma |
0.203 |
0.846 |
<0.001 |
UVM |
Uveal Melanoma |
0.206 |
0.061 |
0.592 |
ACC |
Adrenocortical carcinoma |
0.248 |
0.867 |
<0.001 |
BRCA |
Breast invasive carcinoma |
0.270 |
0.820 |
<0.001 |
READ |
Rectum adenocarcinoma |
0.289 |
0.625 |
<0.001 |
BLCA |
Bladder Urothelial Carcinoma |
0.294 |
0.883 |
<0.001 |
LIHC |
Liver hepatocellular carcinoma |
0.319 |
0.677 |
<0.001 |
KICH |
Kidney Chromophobe |
0.331 |
0.925 |
<0.001 |
PAAD |
Pancreatic adenocarcinoma |
0.347 |
0.768 |
<0.001 |
DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
0.419 |
0.380 |
0.008 |
HNSC |
Head and Neck squamous cell carcinoma |
0.445 |
0.815 |
<0.001 |
TGCT |
Testicular Germ Cell Tumors |
0.463 |
0.838 |
<0.001 |
UCS |
Uterine Carcinosarcoma |
0.499 |
0.705 |
<0.001 |
KIRC |
Kidney renal clear cell carcinoma |
0.539 |
0.421 |
<0.001 |
LGG |
Brain Lower Grade Glioma |
0.644 |
0.091 |
0.037 |
OV |
Ovarian serous cystadenocarcinoma |
0.670 |
0.866 |
<0.001 |
KIRP |
Kidney renal papillary cell carcinoma |
0.751 |
0.773 |
<0.001 |
COAD |
Colon adenocarcinoma |
0.758 |
0.680 |
<0.001 |